Experimental Treatment for Neuroblastoma Earns Rare Pediatric Disease Designation
source: pixabay.com

Experimental Treatment for Neuroblastoma Earns Rare Pediatric Disease Designation

According to a story from BioSpace, the radiopharmaceutical company Clarity Pharmaceuticals has recently announced that the US Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation to its…

Continue Reading Experimental Treatment for Neuroblastoma Earns Rare Pediatric Disease Designation

FDA Grants Orphan Drug Designation to Cellectar’s CLR 131 for the Sixth Time

  The biopharmaceutical company Cellectar Biosciences recently announced that the FDA granted its lead phospholipid drug conjugate, CLR 131, Orphan Drug Designation(ODD) for treatment of lymphoplasmacytic lymphoma. ODD is granted by…

Continue Reading FDA Grants Orphan Drug Designation to Cellectar’s CLR 131 for the Sixth Time
After Losing His Son to Neuroblastoma, This Father is Singing to Raise Money for Cancer Support
Didgeman / Pixabay

After Losing His Son to Neuroblastoma, This Father is Singing to Raise Money for Cancer Support

According to a story from falmouthpacket.co.uk, couple Geoff and Judie Davis were devastated when their two year old boy Mikey died after being diagnosed with neuroblastoma. That was more than…

Continue Reading After Losing His Son to Neuroblastoma, This Father is Singing to Raise Money for Cancer Support
Mother of Boy with Neuroblastoma Speaks Out After Drug The Helped Her Son Rejected for the NHS
source: pixabay.com

Mother of Boy with Neuroblastoma Speaks Out After Drug The Helped Her Son Rejected for the NHS

According to a story from the Yorkshire Evening Post, five-year-old Toby Nye, from Leeds, has been seeing significant benefit from an antibody therapy treatment for his neuroblastoma. The therapy is…

Continue Reading Mother of Boy with Neuroblastoma Speaks Out After Drug The Helped Her Son Rejected for the NHS